Devin W. Steenkamp, MBChB

Assistant Professor, Medicine

Devin Steenkamp
617.414.2938
732 Harrison Ave

Biography

Devin Steenkamp is an academic diabetologist with a focus on type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program at Boston Medical Center and Boston University School of Medicine and his clinical practice is focused on the use of diabetes technologies in care. In addition, he is the principal investigator on a variety of clinical trials related to diabetes pharmacotherapy and the application of novel diabetes technologies.

Education

  • University of Pretoria, MBChB

Publications

  • Published on 12/1/2019

    Modzelewski KL, Fantasia KL, Steenkamp DW. Reconsidering Meaningful Outcomes in Diabetes mHealth Research. US Endocrinology. 2019; 2(15):74-76.

    Read at: Custom
  • Published on 10/3/2019

    Fantasia KL, Steenkamp DW. Optimal Glycemic Control in a Patient With HNF1A MODY With GLP-1 RA Monotherapy: Implications for Future Therapy. J Endocr Soc. 2019 Dec 01; 3(12):2286-2289. PMID: 31737858.

    Read at: PubMed
  • Published on 6/1/2019

    Steenkamp D. CONTINUOUS GLUCOSE MONITORING AS A HYPOGLYCEMIA MITIGATION TOOL IN INDIVIDUALS WITH TYPE 1 DIABETES WITH IMPAIRED HYPOGLYCEMIC AWARENESS. Endocr Pract. 2019 Jun; 25(6):619-621. PMID: 31242124.

    Read at: PubMed
  • Published on 5/1/2019

    Steenkamp DW, Cacicedo JM, Sullivan CA. Comment on Sims et al. Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes. Diabetes Care 2019;42:258-264. Diabetes Care. 2019 05; 42(5):e84. PMID: 31010951.

    Read at: PubMed
  • Published on 5/1/2019

    Stockman MC, Modzelewski K, Steenkamp D. Mobile Health and Technology Usage by Patients in the Diabetes, Nutrition, and Weight Management Clinic at an Urban Academic Medical Center. Diabetes Technol Ther. 2019 07; 21(7):400-405. PMID: 31045447.

    Read at: PubMed
  • Published on 1/13/2019

    Fantasia K, Modzelewski K, Steenkamp D. Predictive Glucose Trends From Continuous Glucose Monitoring: Friend or Foe in Clinical Decision Making? J Diabetes Sci Technol. 2019 Sep; 13(5):963-966. PMID: 30636438.

    Read at: PubMed
  • Published on 11/9/2018

    Sullivan CA, Cacicedo JM, Rajendran I, Steenkamp DW. Comparison of proinsulin and C-peptide secretion in healthy versus long-standing type 1 diabetes mellitus cohorts: A pilot study. PLoS One. 2018; 13(11):e0207065. PMID: 30412637.

    Read at: PubMed
  • Published on 6/29/2018

    Rodriguez-Diaz E, Rizo I, Sullivan C, Steenkamp DW. Perioperative Use of a Hybrid Closed Loop System in an Obese Patient With Type 1 Diabetes Undergoing Metabolic Surgery: Insights Into Changes in Insulin Delivery and Sensitivity. J Diabetes Sci Technol. 2018 11; 12(6):1239-1240. PMID: 29957042.

    Read at: PubMed
  • Published on 12/4/2017

    Jones Iv AR, Coleman EL, Husni NR, Deeney JT, Raval F, Steenkamp D, Dooms H, Nikolajczyk BS, Corkey BE. Type 1 diabetes alters lipid handling and metabolism in human fibroblasts and peripheral blood mononuclear cells. PLoS One. 2017; 12(12):e0188474. PMID: 29206239.

    Read at: PubMed
  • Published on 11/16/2017

    Steenkamp DW, Cacicedo JM, Sahin-Efe A, Sullivan C, Sternthal E. PRESERVED PROINSULIN SECRETION IN LONG-STANDING TYPE 1 DIABETES. Endocr Pract. 2017 Dec; 23(12):1387-1393. PMID: 29144809.

    Read at: PubMed

View 23 more publications: View full profile at BUMC

View all profiles